2ILKova H,Glaser B,Tunckale A,et al.Induction of long-term glycemic control in newly diagnosed type 2diabetic patients by transient intensive insulin treatment[J].Diabetes Care,1997,20:1353.
6Li YB,Xu W,Liao ZH,et al.Induction of long-term glycemic control in new ly diagnosed type 2 diabetic patients is associated with improvement of β-cell function[J].Diabetes Care,2004,27:2597.
3HARSCH IA.Inhaled insulins:their potential in the treatment of diabetes mellitus[J].Treat Endocrinol,2005,4(3):131-138.
4de FRONZO RA,BERGENSTAL RM,CEFALU WT,et al.Efficacy of inhaled insulin in patients with type 2 diabetes not controlled with diet and exercise:a 12-week,randomized,comparative trial[J].Diabetes Care,2005,28(8):1922-1928.
5HOLLANDER PA,BLONDE L,ROWE R,et al.Efficacy and safety of inhaled insulin (exubera) compared with subcutaneous insulin therapy in patients with type 2 diabetes:results of a 6-month,randomized,comparative trial[J].Diabetes Care,2004,27(1):2356-2362.
6RAVE KM,NOSEK L,de la PENA A,et al.Dose response of inhaled dry-powder insulin and dose equivalence to subcutaneous insulin lispro[J].Diabetes Care,2005,28(10):2400-2405.
7ROSENSTOCK J,ZINMAN B,MURPHY LJ,et al.Inhaled insulin improves glycemic control when substituted for or added to oral combination therapy in type 2 diabetes:a randomized controlled trial[J].Ann Intern Med,2005,143(8):549-558.
8QUATTRIN T,BELANGER A,BOHANNON NJ,et al.Efficacy and safety of inhaled insulin(Exubera)compared with subcutaneous insulin therapy in patients with type 1 diabetes:results of a 6-month,randomized,comparative trial[J].Diabetes Care,2004,27 (11):2622-2627.
9Dupuy O,Mayaudon H,Palou M,et al.Optimized transient insulin infusion in uncontrolled type 2 diabetes:evaluation of a pragmatic attitude.Diabetes Metab,2000,26:371-375.
10Melissa K,Cavaghan,Ehrmann DA,et al.Interactions between insulin resistance and insulin secretion in the development of glucose intolerance.J Clin Invest,2000,106:329-333.
3Colquitt, Green C,Sidhu MK, et al. Clinical and cost - effectiveness of continuous subcutaneous insulin infusion for diabetes [ J ]. Heath Technology Assessment, 2004,8 (43) :iii,1-171.
4Feichtner F, Mader JK,Schaller R, et al. A stepwise approach toward closed-loop blood glucose control for intensive care unit patients: results from a feasibility study in type 1 diabetic subjects using vascular microdialysis with infrared spectrometry and a model predictive control algorithm[J]. J Diabetes Sci Technol, 2011,5 (4) :901-905.
5Inzucchi S E,Bergenstal R M,Buse J B,et al.Man-agement of hyperglycaemia in type 2diabetes:apatient-centered approach.Position statement of the AmericanDiabetes Association(ADA)and the European Associa-tion for the Study of Diabetes(EASD)[J].Diabetolo-gia,2012,55(6):1577-1596.
6DCCT Research Group.Diabetes Control and Complica-tions Trial(DCCT):the effect of intensive treatment ofdiabetes on the development and progression of long-term complications in insulin dependent diabetes melli-tus[J].N Engl J Med,1993,329(14):977-86.
7Turnbull F M,Abraira C,Anderson R J,et al.Inten-sive glucose control and macrovascular outcomes in type2diabetes[J].Diabetologia,2009,52(11):2288-2298.
8Rensing K L,von der Thüsen J H,Weijers E M,et al.Endothelial insulin receptor expression in human athero-sclerotic plaques:linking micro-and macrovascular dis-ease in diabetes?[J].Atherosclerosis,2012,222(1):208-215.
9Obrosova IG.Diabetes and the peripheral nerve[J].Biochimica et Biophysica Acta(BBA)–Molecular Ba-sis of Disease,2009,1792(10):1-39.
